UBS Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
UBS Group's AGIO Position: Q3 2026 in Review
UBS Group reduced its Agios Pharmaceuticals (AGIO) stake by 6.5% in Q3 2026, selling an estimated $2.26M and leaving 921,337 shares worth $30.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2196.
UBS Group first reported a position in AGIO in Q4 2014 and has held it in 48 quarters since. The position peaked at $36.6M in Q2 2026. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- UBS Group held 921,337 shares of Agios Pharmaceuticals worth $30.6M as of Q3 2026.
- UBS Group sold 64,494 Agios Pharmaceuticals shares in Q3 2026, an estimated $2.26M.
- Agios Pharmaceuticals made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2196 holding.
- UBS Group first reported a position in Agios Pharmaceuticals in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Agios Pharmaceuticals position peaked at $36.6M in Q2 2026.
- 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.